Timing of antiretroviral therapy for HIV-infected patients with moderate to severe Pneumocystis pneumonia: study protocol for a multi-centre prospective randomised controlled trial

Timing of antiretroviral therapy for HIV-infected patients with moderate to severe Pneumocystis pneumonia: study protocol for a multi-centre prospective randomised controlled trial

Abstract Background Pneumocystis pneumonia (PCP) is a common acquired immune deficiency syndrome (AIDS)-related opportunistic infection. Recent reports estimate that more than 400,000 patients with human immunodeficiency virus (HIV) develop PCP each year globally. However, the timing of antiretrovir...

Full description

Bibliographic Details
Main Authors: Yuanyuan Qin, Yanqiu Lu, Yihong Zhou, Vijay Harypursat, Feng Sun, Sen Yang, Shengquan Tang, Yao Li, Xiaoqing He, Yanming Zeng, Yaokai Chen
Format: Article
Language:English
Published: BMC 2020-06-01
Series:Trials
Subjects:
HIV
Opportunistic infections
Pneumocystis pneumonia
Antiretroviral therapy
Initiation
Randomised controlled trial
Online Access:http://link.springer.com/article/10.1186/s13063-020-04450-8

Internet

http://link.springer.com/article/10.1186/s13063-020-04450-8

Similar Items